Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Covington
Farmers Insurance
Citi
Fuji

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 9,695,437

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,695,437
Title:Constitutive photomorphogenesis 1 (COP1) nucleic acid sequence from zea mays and its use thereof
Abstract: The present invention relates to an isolated COP1 nucleic acid sequence from a maize plant and the isolated COP1 nucleic acid sequence is named as ZmCOP1. The present invention also relates to a method of using the ZmCOP1 nucleic acid sequence to control the shade avoidance response of a crop plant for high density farming and yield enhancement.
Inventor(s): Cheikh; Nordine (Davis, CA), Deng; Molian (Grover, MO), Miller; Philip W. (Ballwin, MO), Xu; Nanfei (Wildwood, MO)
Assignee: Monsanto Technology LLC (St. Louis, MO)
Application Number:14/315,012
Patent Claims:see list of patent claims

Details for Patent 9,695,437

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Monsanto Technology LLC (St. Louis, MO) 2021-08-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Monsanto Technology LLC (St. Louis, MO) 2021-08-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Monsanto Technology LLC (St. Louis, MO) 2021-08-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Covington
Cantor Fitzgerald
Citi
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.